Literature DB >> 15784843

The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension.

Liliana Monica Bivol1, Oyvind Brune Vågnes, Bjarne Magnus Iversen.   

Abstract

The ANG II receptor 1 (AT(1)R) level in the nonclipped kidney of two-kidney, one-clip hypertension (2K1C) has shown to be unchanged despite a high circulating angiotensin (ANG) II level. To examine the vasoreactive response to ANG II in this kidney, injections of ANG II into renal artery were performed 6 wk after clipping of the kidney and compared with normotensive controls. The renal blood flow (RBF) response to 2.5 ng ANG II was measured by a Transonic transit-time flowmeter, before and after indomethacin and candesartan treatment, and analyzed by a computer program. The RBF response to 5 ng arginine-vasopressin (AVP) was examined for comparison with ANG II. The mRNA for AT(1A) and AT(1B) as well as Western blotting for AT(1)R in renal resistance vessels were determined, and plasma renin activity (PRA) was measured. Systolic blood pressure was 183 +/- 4 mmHg in 2K1C rats compared with 113 +/- 1 mmHg in controls (P < 0.001). PRA was significantly increased in 2K1C animals (P < 0.05). Injection of ANG II reduced RBF with 10 +/- 2% in the nonclipped kidney and 24 +/- 3% in controls (P < 0.001). After indomethacin, the RBF response increased from 10 +/- 2 to 20 +/- 3% (P < 0.02) in 2K1C rats and from 24 +/- 3 to 34 +/- 6% in controls (P < 0.01). The doses of candesartan needed to completely inhibit RBF response to ANG II were 30 microg/kg in the nonclipped kidney and 100 microg/kg in controls (P < 0.001). Western blotting and mRNA for AT(1A) and AT(1B) in the nonclipped kidney were similar to the controls. The results indicate that despite no difference in total AT(1)R levels, functional AT(1)R is downregulated in the nonclipped kidney of 2K1C rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784843     DOI: 10.1152/ajprenal.00319.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  5 in total

1.  Mas Receptor Blockade Promotes Renal Vascular Response to Ang II after Partial Kidney Ischemia/Reperfusion in a Two-Kidney-One-Clip Hypertensive Rats Model.

Authors:  Farzaneh Karimi; Mehdi Nematbakhsh
Journal:  Int J Nephrol       Date:  2021-04-20

2.  Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy.

Authors:  Alex A Gutsol; Paula Blanco; Taben M Hale; Jean-Francois Thibodeau; Chet E Holterman; Rania Nasrallah; Jose W N Correa; Sergey A Afanasiev; Rhian M Touyz; Chris R J Kennedy; Dylan Burger; Richard L Hébert; Kevin D Burns
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

Review 3.  Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors.

Authors:  Hajaralsadat Hosseini-Dastgerdi; Fatemeh Kharazmi; Ali-Asghar Pourshanazari; Mehdi Nematbakhsh
Journal:  Int J Nephrol       Date:  2022-10-10

Review 4.  Aminopeptidases in Cardiovascular and Renal Function. Role as Predictive Renal Injury Biomarkers.

Authors:  Félix Vargas; Rosemary Wangesteen; Isabel Rodríguez-Gómez; Joaquín García-Estañ
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

Review 5.  New insights into the importance of aminopeptidase A in hypertension.

Authors:  Shigehiko Mizutani; Masakazu Ishii; Akira Hattori; Seiji Nomura; Yasushi Numaguchi; Masafumi Tsujimoto; Hiroshi Kobayshi; Toyoaki Murohara; John W Wright
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.